急性膵炎の世界市場レポート 2025年

急性膵炎の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.2％で80億4,000万米ドルに成長します。予測期間の成長は、高齢化の動向、認知度向上と早期診断の取り組み、遺伝的素因の研究、治療方法の進歩などに起因すると考えられます。予測期間における主な動向としては、栄養サポート、患者教育・啓発プログラム、標準化されたプロトコルの導入、再生医療の模索、継続的なモニタリングとフォローアップなどが挙げられます。

ヘルスケア支出の増加は、今後数年間の急性膵炎市場の成長を促進すると予測されます。ヘルスケア支出には、医療サービスおよび関連活動の提供に利用される、財政的および非金銭的なすべてのリソースが含まれます。ヘルスケア支出の増加には、慢性疾患の流行、健康保険の適用範囲の拡大、メンタルヘルス問題に対する意識の高まりなど、いくつかの要因が寄与しています。急性膵炎は、壊死性膵炎、臓器不全、感染症などの重篤な合併症を引き起こす可能性があり、追加治療、手術、長期入院を必要とするため、ヘルスケアコストを大幅に増加させます。例えば、カナダに本部を置く非営利団体Canadian Institute for Health Informationは、2023年の総医療費は前年比2.8％増の3,440億米ドルに達すると予測しています。このように、ヘルスケア支出の増加は、急性膵炎市場の成長を促進する重要な要因です。

肥満の増加により、急性膵炎市場は当面拡大が見込まれます。肥満は、健康リスクをもたらす体脂肪の過剰蓄積を特徴とし、急性膵炎のリスク要因として知られています。肥満の世界の蔓延は、この疾患の発生率を高め、関連治療に対する需要を増加させています。2022年3月、世界保健機関（WHO）は、成人で6億5,000万人、青少年で3億4,000万人、小児で3,900万人、合計約10億人が肥満であると報告しました。さらにWHOの予測によると、2025年までに1億6,700万人の成人と子どもが、太りすぎや肥満が原因で健康問題に直面することになります。このように、肥満の増加は急性膵炎市場の重要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の急性膵炎市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の急性膵炎市場：成長率分析
• 世界の急性膵炎市場の実績：規模と成長、2019～2024年
• 世界の急性膵炎市場の予測：規模と成長、2024～2029年、2034年
• 世界の急性膵炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の急性膵炎市場：原因別、実績と予測、2019～2024年、2024～2029年、2034年
• 胆石
• アルコール
• その他
• 世界の急性膵炎市場：治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 輸液
• 栄養サポート
• 鎮痛剤
• 内視鏡的逆行性胆道膵管造影検査（ERCP）
• その他
• 世界の急性膵炎市場：診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像検査
• 臨床検査
• 世界の急性膵炎市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他
• 世界の急性膵炎市場：胆石のサブセグメンテーション：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胆嚢炎誘発性膵炎
• 胆石症誘発性膵炎
• 世界の急性膵炎市場：アルコールのサブセグメンテーション：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性アルコール性膵炎
• 過度の飲酒による膵炎
• 世界の急性膵炎市場：その他のサブセグメンテーション：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤性膵炎
• 外傷性膵炎
• 感染症誘発性膵炎
• 代謝障害

第7章 地域別・国別分析

• 世界の急性膵炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の急性膵炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 急性膵炎市場：競合情勢
• 急性膵炎市場：企業プロファイル
  • CalciMedica Inc. Overview, Products and Services, Strategy and Financial Analysis
  • SCM Lifescience Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Samsung Bioepis Co Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Global Neurotech Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• B. Braun Melsungen AG
• Medtronic plc
• Boston Scientific Corporation
• Fresenius Kabi AG
• Sun BioPharma Inc.
• Atox Bio Inc.
• D-Pharm Ltd.
• Regeneron Pharmaceuticals Inc.
• Merck & Co Inc
• Olympus Corporation
• Pfizer Inc.
• Ionis Pharmaceuticals Inc.
• Abbott Laboratories
• Dynavax Technologies Corporation
• GlaxoSmithKline plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 急性膵炎市場2029年：新たな機会を提供する国
• 急性膵炎市場2029年：新たな機会を提供するセグメント
• 急性膵炎市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Acute pancreatitis is a medical condition characterized by the inflammation and enlargement of the pancreas during a brief period. This condition is commonly caused by either gallstones or excessive alcohol consumption.

The primary causes of acute pancreatitis include gallstones, alcohol consumption, and other factors. Gallstones, which are solidified deposits in the gallbladder, can lead to pain and inflammation of the pancreas when they obstruct the pancreatic duct, resulting in acute pancreatitis. Treatment options for acute pancreatitis typically involve intravenous fluid administration, nutritional support, analgesics, and procedures such as endoscopic retrograde cholangiopancreatography (ERCP). The diagnosis of acute pancreatitis is carried out through imaging tests and laboratory assessments conducted by hospitals, clinics, and other healthcare facilities.

The acute pancreatitis market research report is one of a series of new reports from The Business Research Company that provides acute pancreatitis market statistics, including acute pancreatitis industry global market size, regional shares, competitors with a acute pancreatitis market share, detailed acute pancreatitis market segments, market trends, and opportunities, and any further data you may need to thrive in the acute pancreatitis industry. This acute pancreatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute pancreatitis market size has grown strongly in recent years. It will grow from$5.96 billion in 2024 to $6.31 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to high incidence rates, alcohol consumption patterns, gallstone prevalence, tobacco smoking habits, increasing obesity rates

The acute pancreatitis market size is expected to see strong growth in the next few years. It will grow to $8.04 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to aging population trends, awareness and early diagnosis initiatives, genetic predisposition studies, advancements in treatment modalities. Major trends in the forecast period include focus on nutritional support, patient education and awareness programs, implementation of standardized protocols, exploration of regenerative therapies, continuous monitoring and follow-up.

The rise in healthcare expenditure is anticipated to drive the growth of the acute pancreatitis market in the coming years. Healthcare expenditure encompasses all resources, both financial and non-financial, utilized in delivering health services and related activities. Several factors contribute to the increase in healthcare spending, including the prevalence of chronic diseases, broader health insurance coverage, and heightened awareness of mental health issues. Acute pancreatitis can result in severe complications such as necrotizing pancreatitis, organ failure, and infections, which require additional treatments, surgeries, and extended hospital stays, thereby significantly increasing healthcare costs. For example, the Canadian Institute for Health Information, a nonprofit organization based in Canada, projected that total health expenditure will reach $344 billion in 2023, reflecting a modest growth of 2.8% compared to the previous year. Thus, the rising healthcare expenditure is a key factor propelling the growth of the acute pancreatitis market.

The escalating incidence of obesity is poised to fuel the expansion of the acute pancreatitis market in the foreseeable future. Obesity, characterized by an excessive accumulation of body fat that poses health risks, is a known risk factor for acute pancreatitis. Its increasing global prevalence contributes to a higher incidence of this condition, thereby increasing the demand for related therapies. In March 2022, the World Health Organization reported a staggering figure of approximately 1 billion individuals worldwide-comprising 650 million adults, 340 million adolescents, and 39 million children-who were obese, with this number still on the rise. Additionally, WHO projections suggest that by 2025, 167 million adults and children will face health issues due to being overweight or obese. Thus, the mounting incidence of obesity serves as a key driver for the acute pancreatitis market.

The anticipated rise in gastrointestinal disorders is poised to be a driving factor behind the growth of the acute pancreatitis market in the forthcoming years. These disorders encompass a spectrum of medical issues affecting the gastrointestinal (GI) tract responsible for digestion and nutrient absorption. Conditions such as cholelithiasis, inflammatory bowel disease, and pancreatitis fall under this category, with pancreatitis often linked to or exacerbated by digestive system complications. This inflammation of the pancreas can be triggered by various factors, some of which are associated with the GI tract. For example, data from Crohn's and Colitis UK in March 2022 indicated that in the UK, one in 123 individuals suffers from ulcerative colitis, a type of inflammatory bowel disease known as Crohn's disease, totaling approximately 500,000 inflammatory bowel disease cases in the country. Hence, the increasing prevalence of gastrointestinal disorders is a significant driver fueling growth within the acute pancreatitis market.

Leading companies in the acute pancreatitis market are focusing on developing innovative technologies, such as dry chemistry slide technology, to accurately measure pancreatic lipase levels. This diagnostic method employs a coated slide with dry reagents to conduct chemical reactions for analyzing biological samples, allowing for quick and precise testing without the use of liquid reagents. For example, in June 2024, IDEXX Laboratories Inc., a diagnostics and healthcare innovation firm based in the U.S., launched the catalyst pancreatic lipase test for diagnosing pancreatitis in dogs and cats, which leverages dry chemistry slide technology for accurate pancreatic lipase measurement. The test delivers rapid, quantitative results in less than 10 minutes and integrates smoothly with current workflows, improving diagnostic efficiency. This innovation aims to enhance the early diagnosis and treatment of pancreatitis, a serious condition in pets, and will be further supported by upcoming advancements like the Catalyst SmartQC Control to streamline veterinary diagnostics even more.

In March 2023, CalciMedica Inc., a biopharmaceutical company based in the U.S., merged with Graybug Vision for an undisclosed amount. This merger aims to strengthen the development of CalciMedica's lead product candidate, Auxora, which is intended for treating severe inflammatory diseases, particularly acute pancreatitis, by pooling resources and expertise. Graybug Vision Inc. is also a U.S.-based biopharmaceutical firm that specializes in creating innovative therapies for ocular diseases.

Major companies operating in the acute pancreatitis market include CalciMedica Inc., SCM Lifescience Co. Ltd., Samsung Bioepis Co Ltd., Global Neurotech Pharma Corporation, Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, Boston Scientific Corporation, Fresenius Kabi AG, Sun BioPharma Inc., Atox Bio Inc., D-Pharm Ltd., Regeneron Pharmaceuticals Inc., Merck & Co Inc, Olympus Corporation, Pfizer Inc., Ionis Pharmaceuticals Inc., Abbott Laboratories, Dynavax Technologies Corporation, GlaxoSmithKline plc, AbbVie Inc., Allergan plc, Amgen Inc., AstraZeneca PLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Novartis AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Johnson & Johnson

North America was the largest region in the acute pancreatitis market in 2024. The regions covered in the acute pancreatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the acute pancreatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The acute pancreatitis market includes revenues earned by entities by providing therapies, medications, and procedures aimed at managing and treating the condition. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Pancreatitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute pancreatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute pancreatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute pancreatitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Cause: Gallstones; Alcohol; Other Causes
• 2) By Treatment: Intravenous Fluid; Nutritional Support; Analgesics; Endoscopic Retrograde Cholangiopancreatography (ERCP); Other treatments
• 3) By Diagnosis: Imaging tests; Laboratory Tests
• 4) By End Users: Hospitals; Clinics; Other End-Users
• Subsegments:
• 1) By Gallstones: Cholecystitis-Induced Pancreatitis; Choledocholithiasis-Induced Pancreatitis
• 2) By Alcohol: Acute Alcoholic Pancreatitis; Binge Drinking-Induced Pancreatitis
• 3) By Other Causes: Medications-Induced Pancreatitis; Trauma-Induced Pancreatitis; Infections-Induced Pancreatitis; Metabolic Disorders
• Companies Mentioned: CalciMedica Inc.; SCM Lifescience Co. Ltd.; Samsung Bioepis Co Ltd.; Global Neurotech Pharma Corporation; Baxter International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Pancreatitis Market Characteristics

3. Acute Pancreatitis Market Trends And Strategies

4. Acute Pancreatitis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Acute Pancreatitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acute Pancreatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acute Pancreatitis Market Growth Rate Analysis
• 5.4. Global Acute Pancreatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acute Pancreatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acute Pancreatitis Total Addressable Market (TAM)

6. Acute Pancreatitis Market Segmentation

• 6.1. Global Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gallstones
• Alcohol
• Other Causes
• 6.2. Global Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Fluid
• Nutritional Support
• Analgesics
• Endoscopic Retrograde Cholangiopancreatography (ERCP)
• Other treatments
• 6.3. Global Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging tests
• Laboratory Tests
• 6.4. Global Acute Pancreatitis Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End-Users
• 6.5. Global Acute Pancreatitis Market, Sub-Segmentation Of Gallstones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cholecystitis-Induced Pancreatitis
• Choledocholithiasis-Induced Pancreatitis
• 6.6. Global Acute Pancreatitis Market, Sub-Segmentation Of Alcohol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Alcoholic Pancreatitis
• Binge Drinking-Induced Pancreatitis
• 6.7. Global Acute Pancreatitis Market, Sub-Segmentation Of Other Causes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications-Induced Pancreatitis
• Trauma-Induced Pancreatitis
• Infections-Induced Pancreatitis
• Metabolic Disorders

7. Acute Pancreatitis Market Regional And Country Analysis

• 7.1. Global Acute Pancreatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acute Pancreatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Pancreatitis Market

• 8.1. Asia-Pacific Acute Pancreatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Pancreatitis Market

• 9.1. China Acute Pancreatitis Market Overview
• 9.2. China Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Pancreatitis Market

• 10.1. India Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Pancreatitis Market

• 11.1. Japan Acute Pancreatitis Market Overview
• 11.2. Japan Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Pancreatitis Market

• 12.1. Australia Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Pancreatitis Market

• 13.1. Indonesia Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Pancreatitis Market

• 14.1. South Korea Acute Pancreatitis Market Overview
• 14.2. South Korea Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Pancreatitis Market

• 15.1. Western Europe Acute Pancreatitis Market Overview
• 15.2. Western Europe Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Pancreatitis Market

• 16.1. UK Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Pancreatitis Market

• 17.1. Germany Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Pancreatitis Market

• 18.1. France Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Pancreatitis Market

• 19.1. Italy Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Pancreatitis Market

• 20.1. Spain Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Pancreatitis Market

• 21.1. Eastern Europe Acute Pancreatitis Market Overview
• 21.2. Eastern Europe Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Pancreatitis Market

• 22.1. Russia Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Pancreatitis Market

• 23.1. North America Acute Pancreatitis Market Overview
• 23.2. North America Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Pancreatitis Market

• 24.1. USA Acute Pancreatitis Market Overview
• 24.2. USA Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Pancreatitis Market

• 25.1. Canada Acute Pancreatitis Market Overview
• 25.2. Canada Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Pancreatitis Market

• 26.1. South America Acute Pancreatitis Market Overview
• 26.2. South America Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Pancreatitis Market

• 27.1. Brazil Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Pancreatitis Market

• 28.1. Middle East Acute Pancreatitis Market Overview
• 28.2. Middle East Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Pancreatitis Market

• 29.1. Africa Acute Pancreatitis Market Overview
• 29.2. Africa Acute Pancreatitis Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acute Pancreatitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acute Pancreatitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Pancreatitis Market Competitive Landscape And Company Profiles

• 30.1. Acute Pancreatitis Market Competitive Landscape
• 30.2. Acute Pancreatitis Market Company Profiles
  • 30.2.1. CalciMedica Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. SCM Lifescience Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Samsung Bioepis Co Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Global Neurotech Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Acute Pancreatitis Market Other Major And Innovative Companies

• 31.1. B. Braun Melsungen AG
• 31.2. Medtronic plc
• 31.3. Boston Scientific Corporation
• 31.4. Fresenius Kabi AG
• 31.5. Sun BioPharma Inc.
• 31.6. Atox Bio Inc.
• 31.7. D-Pharm Ltd.
• 31.8. Regeneron Pharmaceuticals Inc.
• 31.9. Merck & Co Inc
• 31.10. Olympus Corporation
• 31.11. Pfizer Inc.
• 31.12. Ionis Pharmaceuticals Inc.
• 31.13. Abbott Laboratories
• 31.14. Dynavax Technologies Corporation
• 31.15. GlaxoSmithKline plc

32. Global Acute Pancreatitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Pancreatitis Market

34. Recent Developments In The Acute Pancreatitis Market

35. Acute Pancreatitis Market High Potential Countries, Segments and Strategies

• 35.1 Acute Pancreatitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acute Pancreatitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acute Pancreatitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer